MKI67 and breast cancer: A case-control study involving 65 male breast cancer patients from the Department of Veteran’s Affairs (DVA) Cancer Registry found that the survival rate was higher for ER-positive patients, while PR status and Ki67 were not associated with survival in men with breast cancer (29).